[The anaphylactoid reaction after colloid infusion]
- PMID: 72035
[The anaphylactoid reaction after colloid infusion]
Abstract
All colloidal volume substitutes carry the risk of anaphylactoid reactions. The general incidence of 0.03% is low; however severe complications can occur. There are differnet pathomechanisms involved in the induction of anaphylactoid reactions after infusion of different colloids. Protein aggregates are of pathogenic importance in human serum albumin incompatibility. The addition of stabilizers to the plasma protein solutions can alter the immunogenicity of the protein molecule. Antibodies of the classes IgG and IgM seem to play a role in severe dextran incompatibility. There was a direct correlation of the intensity of the clinical symptoms with the anti-dextran-antibody titer.
Similar articles
-
[Incidence of anaphylactoid reactions following infusion with colloid volume substitutes].Chir Forum Exp Klin Forsch. 1977 Apr:31-5. Chir Forum Exp Klin Forsch. 1977. PMID: 87295 German.
-
Anaphylactoid reactions to plasma substitutes.Int Anesthesiol Clin. 1985 Fall;23(3):67-95. Int Anesthesiol Clin. 1985. PMID: 2411667
-
Incidence and severity of anaphylactoid reactions to colloid volume substitutes.Lancet. 1977 Feb 26;1(8009):466-9. doi: 10.1016/s0140-6736(77)91953-5. Lancet. 1977. PMID: 65572 Clinical Trial.
-
Toxic effects of colloids in the intensive care unit.Crit Care Clin. 1991 Jul;7(3):713-23. Crit Care Clin. 1991. PMID: 1713807 Review.
-
[Effects and adverse effects of colloid-containing solutions].Beitr Infusionther Klin Ernahr. 1979;2:43-50. Beitr Infusionther Klin Ernahr. 1979. PMID: 94260 Review. German. No abstract available.